Drug Adverse Events and System Complications of Intrathecal Opioid Delivery for Pain: Origins, Detection, Manifestations, and Management

Naumann, Claus; Erdine, Serdar; Koulousakis, A.; Buyten, Jean‐Pierre Van; Schuchard, Marilee

doi:10.1046/j.1525-1403.1999.00092.x

Cited by 63 publications

(47 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The common side effects of IT analgesia included pruritus, dizziness, nausea, abnormal gait, erectile dysfunction, weight gain, memory impairment, confusion, and urinary retention [10,11,13,16,17,[22][23][24][25][26][27][28].…”

Section: Literature Reviewmentioning

confidence: 99%

Eliciting health state utilities from the general public for severe chronic pain

et al. 2009

View full text Add to dashboard Cite

show abstract

Section: Literature Reviewmentioning

confidence: 99%

Eliciting health state utilities from the general public for severe chronic pain

et al. 2009

View full text Add to dashboard Cite

show abstract

“…The use of this therapeutic modality is not without complications. There are the complications resulting from use of the medication, those related to the surgical technique, and the mechanical complications from the implanted delivery system (15,16).…”

Section: Introductionmentioning

confidence: 99%

Continuous Morphine Infusion: A Retrospective Study of Efficacy, Safety, and Demographic Variables

Reig¹,

Abejón

2009

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

“…Systemstörungen werden in der Literatur in den nachstehend genannten Häu-figkeiten angegeben [1, 37,58,90]:…”

Section: Komplikationen Bei Intrathekaler Pharmakotherapieunclassified

Standardisierung invasiver neuromodulativer Verfahren

Harke

Rosenow²,

Tronnier³

et al. 2003

Der Schmerz

View full text Add to dashboard Cite

The Working Group on Neuromodulation of the German Association for the Study of Pain, composed of representatives from various scientific specialty societies, met on December 9, 2000, March 24, 2001, October 5, 2001, and December 8, 2001. As a result of these discussions grounded in current knowledge, the following guidelines were formulated for the standardization of invasive techniques of neuromodulation intended to serve as a systematic aid in decision-making and to provide recommendations for practice-oriented methods. The guidelines were based on both the clinical and practical experience of the group participants (see information box on the next page) as well as on the current scientific literature and guidance from the consensus report of the European Federation of IASP Chapters (EFIC) [23]. The guidelines serve the purpose of orientation and have no effect on either assumption of liability or discharge from liability. The guidelines were conceived for use by physicians in private practice,doctors in hospitals,and nonmedical personnel concerned with the care of chronic pain patients. The Working Group consists of unsalaried volunteers. The participants received no honorarium and were only reimbursed for normal travel expenses in accordance with customary directives. The guidelines will be revised should new scientific results become available, at the latest in 2 years. The plan exists to further develop the guidelines to stages II and III (AWMF). The Steering Committee of the DGSS appraised the guidelines and authorized the guidelines before publication.

show abstract

Drug Adverse Events and System Complications of Intrathecal Opioid Delivery for Pain: Origins, Detection, Manifestations, and Management

Cited by 63 publications

References 65 publications

Eliciting health state utilities from the general public for severe chronic pain

Eliciting health state utilities from the general public for severe chronic pain

Continuous Morphine Infusion: A Retrospective Study of Efficacy, Safety, and Demographic Variables

Standardisierung invasiver neuromodulativer Verfahren

Contact Info

Product

Resources

About